The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 14,074,530 | 90,821 | SH | SOLE | NONE | 90,821 | 0 | 0 | ||
APOGEE THERAPEUTICS INC | COM | 03770N101 | 290,045 | 10,381 | SH | SOLE | NONE | 10,381 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 13,025,162 | 34,238 | SH | SOLE | NONE | 34,238 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 12,847,147 | 190,752 | SH | SOLE | NONE | 190,752 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 6,991,822 | 87,848 | SH | SOLE | NONE | 87,848 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 2,785,092 | 28,885 | SH | SOLE | NONE | 28,885 | 0 | 0 | ||
BIOMEA FUSION INC | COM | 09077A106 | 369,563 | 25,452 | SH | SOLE | NONE | 25,452 | 0 | 0 | ||
CHARLES RIV LABS INTL INC | COM | 159864107 | 1,632,342 | 6,905 | SH | SOLE | NONE | 6,905 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 2,681,114 | 32,113 | SH | SOLE | NONE | 32,113 | 0 | 0 | ||
CYTOKINETICS INC | CALL | 23282W905 | 33,805,101 | 404,900 | SH | Call | SOLE | NONE | 404,900 | 0 | 0 | |
CYTOKINETICS INC | PUT | 23282W955 | 33,437,745 | 400,500 | SH | Put | SOLE | NONE | 400,500 | 0 | 0 | |
ELI LILLY & CO | COM | 532457108 | 53,974,312 | 92,593 | SH | SOLE | NONE | 92,593 | 0 | 0 | ||
ELI LILLY & CO | PUT | 532457958 | 23,316,800 | 40,000 | SH | Put | SOLE | NONE | 40,000 | 0 | 0 | |
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 1,155,500 | 50,000 | SH | SOLE | NONE | 50,000 | 0 | 0 | ||
GRITSTONE BIO INC | COM | 39868T105 | 194,147 | 95,170 | SH | SOLE | NONE | 95,170 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 901,456 | 21,397 | SH | SOLE | NONE | 21,397 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 2,322,267 | 74,936 | SH | SOLE | NONE | 74,936 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 2,979,392 | 41,600 | SH | SOLE | NONE | 41,600 | 0 | 0 | ||
MERCK & CO INC | COM | 58933Y105 | 35,889,384 | 329,200 | SH | SOLE | NONE | 329,200 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 5,929,200 | 45,000 | SH | SOLE | NONE | 45,000 | 0 | 0 | ||
NOVO-NORDISK A S | ADR | 670100205 | 74,639,899 | 721,507 | SH | SOLE | NONE | 721,507 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 1,962,400 | 440,000 | SH | SOLE | NONE | 440,000 | 0 | 0 | ||
PLIANT THERAPEUTICS INC | COM | 729139105 | 1,811,000 | 100,000 | SH | SOLE | NONE | 100,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 2,575,956 | 112,340 | SH | SOLE | NONE | 112,340 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 488,004 | 19,638 | SH | SOLE | NONE | 19,638 | 0 | 0 | ||
STRUCTURE THERAPEUTICS INC | PUT | 86366E956 | 407,600 | 10,000 | SH | Put | SOLE | NONE | 10,000 | 0 | 0 | |
TYRA BIOSCIENCES INC | COM | 90240B106 | 142,004 | 10,253 | SH | SOLE | NONE | 10,253 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 2,421,254 | 38,555 | SH | SOLE | NONE | 38,555 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 2,600,105 | 130,790 | SH | SOLE | NONE | 130,790 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 7,138,424 | 383,580 | SH | SOLE | NONE | 383,580 | 0 | 0 | ||
WATERS CORP | COM | 941848103 | 936,659 | 2,845 | SH | SOLE | NONE | 2,845 | 0 | 0 |